Annual FCF
-$175.17 M
+$67.99 M+27.96%
December 31, 2023
Summary
- As of February 12, 2025, CHRS annual free cash flow is -$175.17 million, with the most recent change of +$67.99 million (+27.96%) on December 31, 2023.
- During the last 3 years, CHRS annual FCF has fallen by -$322.08 million (-219.23%).
- CHRS annual FCF is now -219.23% below its all-time high of $146.91 million, reached on December 31, 2020.
Performance
CHRS Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$62.02 M
-$121.75 M-203.82%
September 30, 2024
Summary
- As of February 12, 2025, CHRS quarterly free cash flow is -$62.02 million, with the most recent change of -$121.75 million (-203.82%) on September 30, 2024.
- Over the past year, CHRS quarterly FCF has dropped by -$7.72 million (-14.21%).
- CHRS quarterly FCF is now -203.82% below its all-time high of $59.73 million, reached on June 30, 2024.
Performance
CHRS Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$61.98 M
-$7.72 M-14.22%
September 30, 2024
Summary
- As of February 12, 2025, CHRS TTM free cash flow is -$61.98 million, with the most recent change of -$7.72 million (-14.22%) on September 30, 2024.
- Over the past year, CHRS TTM FCF has increased by +$200.00 million (+76.34%).
- CHRS TTM FCF is now -142.19% below its all-time high of $146.91 million, reached on December 31, 2020.
Performance
CHRS TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
CHRS Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +28.0% | -14.2% | +76.3% |
| 3 y3 years | -219.2% | -59.4% | +74.7% |
| 5 y5 years | -9.4% | -59.4% | +74.7% |
CHRS Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -352.4% | +28.0% | -203.8% | +38.0% | -60.1% | +76.3% |
| 5 y | 5-year | -219.2% | +28.0% | -203.8% | +38.0% | -142.2% | +76.3% |
| alltime | all time | -219.2% | +32.4% | -203.8% | +38.0% | -142.2% | +78.2% |
Coherus BioSciences Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$62.02 M(-203.8%) | -$61.98 M(+14.2%) |
| Jun 2024 | - | $59.73 M(-227.7%) | -$54.27 M(-64.5%) |
| Mar 2024 | - | -$46.77 M(+261.5%) | -$152.92 M(-12.6%) |
| Dec 2023 | -$175.17 M(-28.0%) | -$12.94 M(-76.2%) | -$174.88 M(-33.2%) |
| Sep 2023 | - | -$54.30 M(+39.5%) | -$261.99 M(+6.8%) |
| Jun 2023 | - | -$38.91 M(-43.4%) | -$245.23 M(-4.7%) |
| Mar 2023 | - | -$68.73 M(-31.3%) | -$257.24 M(+5.8%) |
| Dec 2022 | -$243.16 M(+528.0%) | -$100.04 M(+166.4%) | -$243.16 M(+24.1%) |
| Sep 2022 | - | -$37.55 M(-26.3%) | -$195.91 M(+35.2%) |
| Jun 2022 | - | -$50.92 M(-6.8%) | -$144.92 M(+53.2%) |
| Mar 2022 | - | -$54.66 M(+3.5%) | -$94.60 M(+144.3%) |
| Dec 2021 | -$38.72 M(-126.4%) | -$52.79 M(-492.5%) | -$38.72 M(-183.7%) |
| Sep 2021 | - | $13.45 M(-2330.5%) | $46.24 M(-40.7%) |
| Jun 2021 | - | -$603.00 K(-149.3%) | $78.03 M(-42.8%) |
| Mar 2021 | - | $1.22 M(-96.2%) | $136.44 M(-7.1%) |
| Dec 2020 | $146.91 M(+453.7%) | $32.17 M(-28.9%) | $146.91 M(+11.2%) |
| Sep 2020 | - | $45.24 M(-21.7%) | $132.06 M(-6.2%) |
| Jun 2020 | - | $57.81 M(+394.3%) | $140.86 M(+47.4%) |
| Mar 2020 | - | $11.69 M(-32.5%) | $95.55 M(+260.1%) |
| Dec 2019 | $26.53 M | $17.32 M(-67.9%) | $26.53 M(-169.2%) |
| Sep 2019 | - | $54.03 M(+332.4%) | -$38.37 M(-71.7%) |
| Jun 2019 | - | $12.49 M(-121.8%) | -$135.68 M(-26.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | -$57.32 M(+20.5%) | -$183.71 M(+14.8%) |
| Dec 2018 | -$160.06 M(-21.9%) | -$47.58 M(+9.9%) | -$160.06 M(+12.3%) |
| Sep 2018 | - | -$43.28 M(+21.8%) | -$142.51 M(-0.0%) |
| Jun 2018 | - | -$35.53 M(+5.6%) | -$142.56 M(-12.8%) |
| Mar 2018 | - | -$33.66 M(+12.1%) | -$163.56 M(-20.2%) |
| Dec 2017 | -$204.86 M(-20.9%) | -$30.03 M(-30.7%) | -$204.86 M(-22.8%) |
| Sep 2017 | - | -$43.33 M(-23.4%) | -$265.29 M(-6.7%) |
| Jun 2017 | - | -$56.53 M(-24.6%) | -$284.41 M(+11.3%) |
| Mar 2017 | - | -$74.97 M(-17.1%) | -$255.56 M(-1.3%) |
| Dec 2016 | -$259.06 M(+126.9%) | -$90.46 M(+44.9%) | -$259.06 M(+57.5%) |
| Sep 2016 | - | -$62.45 M(+125.5%) | -$164.48 M(+0.2%) |
| Jun 2016 | - | -$27.69 M(-64.7%) | -$164.09 M(+3.7%) |
| Mar 2016 | - | -$78.46 M(-2003.1%) | -$158.24 M(+38.6%) |
| Dec 2015 | -$114.15 M(+326.3%) | $4.12 M(-106.6%) | -$114.15 M(-24.9%) |
| Sep 2015 | - | -$62.05 M(+184.0%) | -$152.05 M(+58.4%) |
| Jun 2015 | - | -$21.85 M(-36.4%) | -$95.97 M(+26.9%) |
| Mar 2015 | - | -$34.38 M(+1.8%) | -$75.64 M(+182.5%) |
| Dec 2014 | -$26.78 M(-277.9%) | -$33.77 M(+465.1%) | -$26.78 M(-482.6%) |
| Sep 2014 | - | -$5.98 M(+295.8%) | $7.00 M(-46.1%) |
| Jun 2014 | - | -$1.51 M(-110.4%) | $12.97 M(-10.4%) |
| Mar 2014 | - | $14.48 M | $14.48 M |
| Dec 2013 | $15.05 M(-175.1%) | - | - |
| Dec 2012 | -$20.03 M | - | - |
FAQ
- What is Coherus BioSciences annual free cash flow?
- What is the all time high annual FCF for Coherus BioSciences?
- What is Coherus BioSciences annual FCF year-on-year change?
- What is Coherus BioSciences quarterly free cash flow?
- What is the all time high quarterly FCF for Coherus BioSciences?
- What is Coherus BioSciences quarterly FCF year-on-year change?
- What is Coherus BioSciences TTM free cash flow?
- What is the all time high TTM FCF for Coherus BioSciences?
- What is Coherus BioSciences TTM FCF year-on-year change?
What is Coherus BioSciences annual free cash flow?
The current annual FCF of CHRS is -$175.17 M
What is the all time high annual FCF for Coherus BioSciences?
Coherus BioSciences all-time high annual free cash flow is $146.91 M
What is Coherus BioSciences annual FCF year-on-year change?
Over the past year, CHRS annual free cash flow has changed by +$67.99 M (+27.96%)
What is Coherus BioSciences quarterly free cash flow?
The current quarterly FCF of CHRS is -$62.02 M
What is the all time high quarterly FCF for Coherus BioSciences?
Coherus BioSciences all-time high quarterly free cash flow is $59.73 M
What is Coherus BioSciences quarterly FCF year-on-year change?
Over the past year, CHRS quarterly free cash flow has changed by -$7.72 M (-14.21%)
What is Coherus BioSciences TTM free cash flow?
The current TTM FCF of CHRS is -$61.98 M
What is the all time high TTM FCF for Coherus BioSciences?
Coherus BioSciences all-time high TTM free cash flow is $146.91 M
What is Coherus BioSciences TTM FCF year-on-year change?
Over the past year, CHRS TTM free cash flow has changed by +$200.00 M (+76.34%)